Novo gets warning letter on side effect reporting from the US government

Novo Nordisk has received a warning letter from the U.S. Food and Drug Administration (FDA) regarding its procedures for reporting potential side effects. The letter refers to three deaths, including one suicide, and a case of suicidal thoughts among patients treated with semaglutide—the active ingredient in Ozempic and Wegovy. The FDA is not investigating whether […]